{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT03138408: Phase 1 Interventional Terminated Cancer
(2017)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02848248: Phase 1 Interventional Terminated Acute Myeloid Leukemia
(2016)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03309111: Phase 1 Interventional Completed Relapsed/Refractory Multiple Myeloma
(2017)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03697304: Phase 2 Interventional Completed Neoplasm Metastasis
(2019)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02936102: Phase 1 Interventional Terminated Advanced Solid Tumors
(2016)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03337022: Phase 1 Interventional Completed Psoriasis
(2018)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02947152: Phase 1 Interventional Terminated Epithelial Ovarian Cancer
(2016)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
USAN:ONTERODRIMER [USAN]
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02473731: Phase 1 Interventional Completed Squamous Cell Carcinoma of the Head and Neck
(2015)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT04021043: Phase 1/Phase 2 Interventional Active, not recruiting Advanced Malignant Solid Neoplasm
(2019)
Source URL:
Class:
CONCEPT